−572.84 MUSD
62.84 MUSD
542.56 M
About SORRENTO THERAPEUTICS INC
Sector
Industry
CEO
Henry H. Ji
Website
Headquarters
San Diego
Employees (FY)
949
Founded
1989
ISIN
US83587F2020
FIGI
BBG000BDM2G2
Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments. The Sorrento Therapeutics segment consists of developing a portfolio of next generation treatments for three major therapeutic areas: cancer, infectious disease, and pain. The Scilex segment is largely organized around the company's non-opioid pain management operations. The company was founded by Henry H. Ji in 1989 and is headquartered in San Diego, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SRNE is 0.0240 USD — it has decreased by 14.29% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange SORRENTO THERAPEUTICS INC stocks are traded under the ticker SRNE.
SORRENTO THERAPEUTICS INC is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
SRNE stock is 86.67% volatile and has beta coefficient of −0.64. Check out the list of the most volatile stocks — is SORRENTO THERAPEUTICS INC there?
SRNE earnings for the last quarter are −0.54 USD whereas the estimation was −0.25 USD which accounts for −116.00% surprise. Estimated earnings for the next quarter are −0.26 USD. See more details about SORRENTO THERAPEUTICS INC earnings.
SORRENTO THERAPEUTICS INC revenue for the last quarter amounts to 11.46 M USD despite the estimated figure of 18.75 M USD. In the next quarter revenue is expected to reach 13.60 M USD.
Yes, you can track SORRENTO THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
SRNE stock has risen by 650.00% compared to the previous week, the month change is a 100.00% rise, over the last year SORRENTO THERAPEUTICS INC has showed a 92.99% decrease.
No, SRNE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SRNE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SORRENTO THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 949.00 employees. See our rating of the largest employees — is SORRENTO THERAPEUTICS INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SORRENTO THERAPEUTICS INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SORRENTO THERAPEUTICS INC stock shows the sell signal. See more of SORRENTO THERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.